EUVIMEDEUVIMED entdecken
Open Access

Retraction: miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2

Oncology Research Editorial Office

Oncology Research · 2026 · 34 (5) · 1-10

DOI: 10.32604/or.2026.081623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Oncology Research Editorial Office. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Oncology Research Editorial Office (2026). Retraction: miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2. Oncology Research, 34(5), 1-10. https://doi.org/10.32604/or.2026.081623

Vancouver

Oncology Research Editorial Office. Retraction: miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2. Oncology Research. 2026;34(5):1-10. doi:10.32604/or.2026.081623

BibTeX
@article{OncologyResearchEditorialOffice2026,
  author = {Oncology Research Editorial Office, Oncology Research Editorial Office},
  title = {Retraction: miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2},
  journal = {Oncology Research},
  year = {2026},
  volume = {34},
  number = {5},
  pages = {1--10},
  doi = {10.32604/or.2026.081623}
}
Kostenlos starten →